Researchers find older adults rarely discuss cannabis use with clinicians – Medical Xpress
#76 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Older adults’ reluctance to disclose cannabis use to clinicians creates a significant clinical blind spot, as this population may be taking cannabis for pain, sleep, or other conditions without medical oversight or knowledge of potential drug interactions with their medications. Clinicians need to proactively ask older patients about cannabis use during history-taking to identify safety risks, optimize treatment plans, and provide evidence-based guidance on efficacy and dosing for age-related conditions. This communication gap is particularly critical in geriatric and palliative care settings where polypharmacy and complex medical conditions increase vulnerability to adverse cannabis-related effects.
A recent study reveals that older adults infrequently disclose cannabis use to their healthcare providers, creating a significant gap in medical documentation and patient safety monitoring. This communication barrier is particularly concerning in geriatric populations who may use cannabis for pain management, sleep, or palliative care, as older adults are more susceptible to drug interactions, cognitive effects, and falls related to cannabinoid use. The findings suggest that clinicians may be underestimating cannabis prevalence in their older patient populations and missing opportunities to assess potential harms, drug interactions with common medications like anticoagulants or sedatives, and to provide evidence-based guidance on safer use. This disclosure gap may stem from patient concerns about clinician judgment, fear of legal consequences, or uncertainty about whether cannabis use is relevant to their medical care. Clinicians should proactively create a non-judgmental environment for discussing substance use, including cannabis, by normalizing these conversations as part of comprehensive medication and supplement reviews, particularly during initial assessments and when evaluating new symptoms in older patients. To improve patient safety and quality of care, physicians should explicitly ask about cannabis use in older adults and document it in the medical record just as they would any other medication or supplement.
“The communication gap we’re seeing with older patients and cannabis is a clinical liability we can’t ignore: patients are self-managing symptoms without medical oversight, we’re missing drug interactions and contraindications, and we’re losing the opportunity to discuss evidence-based dosing and safer alternatives. If we want to practice good medicine in an aging population dealing with chronic pain, insomnia, and anxiety, we have to normalize these conversations in our offices the same way we do with alcohol or supplements.”
💊 The apparent communication gap between older adults and their healthcare providers regarding cannabis use represents a significant blind spot in clinical practice, particularly as cannabis legalization expands access and use among seniors increases. This disconnect is clinically concerning because older patients may have multiple comorbidities, polypharmacy regimens, and age-related pharmacokinetic changes that make cannabis interactions and adverse effects more likely—yet providers cannot address risks they do not know exist. The reasons for non-disclosure likely include patient stigma, assumptions that clinicians disapprove, generational hesitancy about discussing substance use, and provider discomfort or knowledge gaps about cannabis in older populations. Healthcare providers should recognize that direct, non-judgmental inquiry about cannabis use (including hemp-derived and over-the-counter products) should be integrated into standard medication and substance use histories, particularly for older adults reporting chronic pain, insomnia, or anxiety. Creating an environment where older patients feel
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
